Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)
- Previous Close
67.40 - Open
67.17 - Bid 68.41 x --
- Ask 68.45 x --
- Day's Range
67.01 - 68.66 - 52 Week Range
46.52 - 69.96 - Volume
598,696 - Avg. Volume
761,674 - Market Cap (intraday)
4.013B - Beta (5Y Monthly) 0.95
- PE Ratio (TTM)
145.64 - EPS (TTM)
0.47 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 30, 2022
- 1y Target Est
--
Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. The company was founded in 2010 and is headquartered in Taizhou, China.
www.s-sbio.comRelated News
Performance Overview: 688399.SS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688399.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688399.SS
Valuation Measures
Market Cap
4.01B
Enterprise Value
1.80B
Trailing P/E
145.64
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.65
Price/Book (mrq)
1.11
Enterprise Value/Revenue
1.19
Enterprise Value/EBITDA
21.40
Financial Highlights
Profitability and Income Statement
Profit Margin
-94.79%
Return on Assets (ttm)
--
Return on Equity (ttm)
-10.42%
Revenue (ttm)
405.51M
Net Income Avi to Common (ttm)
-384.39M
Diluted EPS (ttm)
0.47
Balance Sheet and Cash Flow
Total Cash (mrq)
2.54B
Total Debt/Equity (mrq)
9.30%
Levered Free Cash Flow (ttm)
--
Company Insights: 688399.SS
688399.SS does not have Company Insights